HZHuan Zhang

Huan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huan Zhang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Xingbo Mo

    Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, China

    9 shared publications
  • Shu-Feng Lei

    Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, 199 Renai Road, Suzhou, 215123, Jiangsu, People's Republic of China

    4 shared publications
  • Yong-Hong Zhang

    Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, 199 Renai Road, Suzhou, 215123, Jiangsu, People's Republic of China

    4 shared publications
  • Yonghong Zhang

    Soochow University Medical College

    3 shared publications
  • Chengcheng Duan

    Department of Epidemiology, Jiangsu Key Laboratory of Preventive & Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, China

    2 shared publications
  • Qiyu Qian

    Soochow University Medical College

    2 shared publications

Latest Publications

  • Open Access

    Association of cardiorenal biomarkers with mortality in metabolic syndrome patients: A prospective cohort study from NHANES

    by Qianyi Gao, Shuanglong Jia, Xingbo Mo, Huan Zhang

    Objectives: Approximately 20%–25% of the global adult population is affected by metabolic syndrome (MetS), highlighting its status as a major public health concern. This study aims to investigate the predictive value of cardiorenal biomarkers on mortality among patients with MetS, thus optimizing treatment strategies.Methods: Utilizing data from the National Health and Nutrition Examination Survey (NHANES) cycles between 1999 and 2004, we conducted a prospective cohort study involving 2369 participants diagnosed with MetS. We evaluated the association of cardiac and renal biomarkers with all‐cause and cardiovascular disease (CVD) mortality, employing weighted Cox proportional hazards models. Furthermore, machine learning models were used to predict mortality outcomes based on these biomarkers.Results: Among 2369 participants in the study cohort, over a median follow‐up period of 17.1 years, 774 (32.67%) participants died, including 260 (10.98%) from CVD. The highest quartiles of cardiac biomarkers (N‐terminal pro‐B‐type natriuretic peptide [NT‐proBNP]) and renal biomarkers (beta‐2 microglobulin, [β2M]) were significantly associated with increased risks of all‐cause mortality (hazard ratios [HRs] ranging from 1.94 to 2.06) and CVD mortality (HRs up to 2.86), after adjusting for confounders. Additionally, a U‐shaped association was observed between high‐sensitivity cardiac troponin T (Hs‐cTnT), creatinine (Cr), and all‐cause mortality in patients with MetS. Machine learning analyses identified Hs‐cTnT, NT‐proBNP, and β2M as important predictors of mortality, with the CatBoost model showing superior performance (area under the curve [AUC] = 0.904).Conclusion: Cardiac and renal biomarkers are significant predictors of mortality in MetS patients, with Hs‐cTnT, NT‐proBNP, and β2M emerging as crucial indicators. Further research is needed to explore intervention strategies targeting these biomarkers to improve clinical outcomes.


  • Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations

    by Fan Tang, Chengcheng Duan, Ru Li, Huan Zhang, Xingbo Mo

    Introduction: Genome-wide association studies have identified approximately 1000 lipid-associated loci, but functional variants are less known. Materials & methods: The authors identified RNA modif...

  • Open Access

    The Association Between DNA Methylation of CASZ1 Gene and Overweight/obesity in the Chinese Han Population

    by Qiyu Qian, Xingbo Mo, Chengcheng Duan, Aili Wang, Tan Xu, Huan Zhang, Yonghong Zhang

    ObjectiveThe aim of this study was to examine the potential association between castor zinc finger 1 (CASZ1) gene methylation and overweight/obesity, and investigate the interaction effects between CASZ1 methylation levels and some environmental factors on overweight/obesity.MethodsThis study included 1,029 individuals. The methylation levels of CpG sites at CASZ1 promoter were measured with bisulfite sequencing method. Multiple linear regression and logistic regression models were used to analyze the association between CASZ1 methylation and body mass index (BMI) and overweight/obesity, respectively; while additive scale and multiplicative scale were used to evaluate the interaction effects between methylation levels and environmental factors on overweight/obesity.ResultsThe levels of CASZ1 methylation at CpG51, 70, 72, 98, 157, 165 were associated with BMI after adjustments. There were differences between cases and controls in the levels of DNA methylation at CpG58, 72, 98, 116, 157, 163, 165. Methylations at CpG72, 98, 163, 165 were associated with overweight/obesity after adjustments. The association between methylation levels of CpG98 (Odds ratio=1.06, 95%Confidence interval: 1.02-1.10) and CpG165 (Odds ratio =1.15, 95% Confidence interval: 1.07-1.42) and overweight/obesity was significant after considering multiple testing (P < 0.003). Besides, we found significant additive interaction effects of drinking status and triglyceride level with CpG163 on BMI. ConclusionThe methylation levels of CpG sites in CASZ1 gene, as well as the interactions with some environmental factors, were associated with overweight/obesity in the Chinese Han population.

  • Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus

    by Xingbo Mo, Yufan Guo, Qiyu Qian, Mengzhen Fu, Shufeng Lei, Yonghong Zhang, Huan Zhang

    Summary: Genome‐wide association studies (GWAS) have identified many loci for systemic lupus erythematosus (SLE). However, identification of functionally relevant genes remains a challenge. The aim of this study was to highlight potential causal genes for SLE in the GWAS loci. By applying Mendelian randomization (MR) methods, such as summary data‐based MR (SMR), generalized SMR and MR pleiotropy residual sum and outlier, we identified DNA methylations in 15 loci and mRNA expression of 21 genes that were causally associated with SLE. The identified genes enriched in 14 specific KEGG pathways (e.g. SLE, viral carcinogenesis) and two GO terms (interferon‐γ‐mediated signaling pathway and innate immune response). Among the identified genes, UBE2L3 and BLK variants were significantly associated with UBE2L3 and BLK methylations and gene expressions, respectively. UBE2L3 was up‐regulated in SLE patients in several types of immune cells. Methylations (e.g. cg06850285) and mRNA expression of UBE2L3 were causally associated with SLE. Methylation site cg09528494 and mRNA expression of BLK were causally associated with SLE. BLK single nucleotide polymorphisms that were significantly associated with SLE were strongly associated with plasma cathepsin B level. Deep analysis identified that plasma cathepsin B level was causally associated with SLE. In summary, this study identified hundreds of DNA methylations and genes as potential risk factors for SLE. Genetic variants in UBE2L3 gene might affect SLE by influencing gene expression. Genetic variants in BLK gene might affect SLE by influencing BLK gene expression and plasma cathepsin B protein level.


  • Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis

    by Xing-Bo Mo, Shu-Feng Lei, Qi-Yu Qian, Yu-Fan Guo, Yong-Hong Zhang, Huan Zhang

    Objective Many genomic loci have been identified for multiple sclerosis (MS) by genome-wide association studies (GWAS). Discrimination of the most functionally relevant genes in these loci remains challenging. The aim of this study was to highlight potential causal genes for MS. Methods We detected potential causal DNA methylations and gene expressions for MS by integrating data from large scale GWAS and quantitative trait locus (QTL) studies using the summary data-based Mendelian randomization method. Potential functional SNPs in the identified genes were searched. Results We found 178 DNA methylation sites and mRNA expressions of 29 genes that were causally associated with MS. The identified genes enriched in 21 specific KEGG pathways and 80 GO terms (e.g., antigen processing and presentation, interferon gamma mediated signaling pathway). Among the identified non-MHC genes, METTL21B, METTL1 and TSFM were strongly connected. MS-associated SNPs in DDR1 were strongly associated with plasma MHC class I polypeptide-related sequence B (MICB) and Granzyme A levels. And plasma MICB and Granzyme A levels were causally associated with MS. Many SNPs in the causal genes showed QTL effects. The association between m6A-SNPs rs923829 and METTL21B expression level was validated in 40 unrelated Chinese Han individuals. Conclusions This study identified many DNA methylations and genes as important risk factors for MS and provided novel evidence on the association between circulating MICB and Granzyme A and MS. We also showed that the interaction among DDR1, MICB and GZMA and interaction among METTL21B, METTL1 and TSFM may participate in the pathogenesis of MS.


  • Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure

    by Xing-Bo Mo, Shu-Feng Lei, Yong-Hong Zhang, Huan Zhang

    N6-methyladenosine (m6A) has been shown to play critical roles in many biological processes and a variety of diseases. The aim of this study was to investigate the association between m6A-associated single-nucleotide polymorphisms (m6A-SNPs) and blood pressure (BP) in large-scale genome-wide association studies and to test whether m6A-SNPs are enriched among the SNPs that were associated with BP. Furthermore, gene expression analysis was performed to obtain additional evidence for the identified m6A-SNPs. We found 1236 m6A-SNPs that were nominally associated with BP, and 33 of them were significant genome wide. The proportion of m6A-SNPs with a P < 0.05 was significantly higher than that of non-m6A-SNPs. Using fgwas, we found that SNPs associated with diastolic BP (P < 5 × 10–8) were significantly enriched with m6A-SNPs (log 2 enrichment of 2.67, 95% confidence interval: [0.42, 3.68]). Approximately 10% of the BP-associated m6A SNPs were associated with coronary artery disease or stroke. Most of these m6A-SNPs were strongly associated with gene expression. We showed that rs56001051, rs9847953, rs197922, and rs740406 were associated with C1orf167 (P = 0.019), ZNF589 (P = 0.013), GOSR2 (P = 0.001), and DOT1L (P = 0.032) expression levels in peripheral blood mononuclear cells of 40 Chinese individuals, respectively. The present study identified many BP-associated m6A-SNPs and demonstrated their potential functionality. The results suggested that m6A might play important roles in BP regulation.


  • Open Access

    Integrative Analysis Identified IRF6 and NDST1 as Potential Causal Genes for Ischemic Stroke

    by Xing-Bo Mo, Shu-Feng Lei, Yong-Hong Zhang, Huan Zhang

    Objective: To highlight potential functional variants and causal genes for ischemic stroke (IS) in genomic loci identified by genome-wide association studies (GWAS). Methods: We examined the association between m6A-SNPs and IS in large scale GWAS. Furthermore, eQTL analysis was performed to evaluate the effect of m6A-SNPs on gene expression. The top associations between m6A-SNPs and gene expressions were validated in 40 individuals from the Chinese Han population. Besides, we applied differential expression analysis and Mendelian randomization (MR) analysis to detect potential causal genes for IS. Results: We found 310 (7.39%) m6A-SNPs which were nominally associated with IS. The proportion of m6A-SNPs with P < 0.05 for IS was significantly higher than the non-m6A-SNPs (95%CI: [5.84%, 7.36%], P = 0.02). We found that the IS-associated m6A-SNP rs2013162 was associated with IRF6 expression (P = 6.30 × 10−23), meanwhile IRF6 was differentially expressed between IS cases and controls (P = 6.15 × 10−3) and showed a causal association with IS (P = 3.64 × 10−4). Similar results were found for m6A-SNP rs2273235 in the NDST1 gene which was associated with cardioembolic stroke (P = 8.47 × 10−3). The associations of rs2013162 and rs2273235 with the expression of IRF6 and NDST1 were validated in blood cells (P = 0.0247 and 0.0007), respectively. Conclusions: This study showed that m6A-SNPs may affect IS risk through altering gene expressions. The results suggested that m6A might play a role in IS etiology and gene expressions that affected by m6A may be causal factors for IS.


  • Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci

    by Xingbo Mo, Shufeng Lei, Yonghong Zhang, Huan Zhang

    N6-methyladenosine (m6A) plays critical roles in many fundamental biological processes and a variety of diseases. The aim of this study was to investigate the effect of m6A-SNPs on lipid levels. We examined the association of m6A-SNPs with lipid levels in a genome-wide association studies (GWAS) of 188,578 individuals. Furthermore, we performed expression quantitative trait loci and differential expression analyses to add additional information for the identified m6A-SNPs. We found 1,655 m6A-SNPs in the GWAS dataset. Among them, 395 (23.9%) were nominally (P < 0.05) associated with lipid levels, and 22 reached the genome-wide significance level (P < 5.0 × 10−8). Using the fgwas method we found that SNPs, which influence high-density lipoprotein cholesterol (log2 enrichment of 3.35, 95% CI: (0.92, 4.48)) and TG (log enrichment of 3.22, 95% CI: (1.18, 4.44)), were enriched in m6A methylation. The high confidence (determined by miCLIP experiment) m6A-SNP rs6859 at the 3′-untranslated region of PVRL2 was associated with high-density lipoprotein cholesterol (P = 1.21 × 10−15), low-density lipoprotein cholesterol (P = 1.77 × 10−106), total cholesterol (P = 4.82 × 10−82), and triglycerides (P = 8.10 × 10−5) levels, coronary artery disease (P = 0.01), as well as PVRL2 mRNA expression in artery tibial (P = 2.38 × 10−6) and whole blood (P = 5.59 × 10−19). Moreover, PVRL2 was differentially expressed in adipose tissue of familial combined hyperlipidemia (P = 9.27 × 10−4). The present study found plenty of lipid-associated m6A-SNPs and demonstrated that m6A-SNPs may play important roles in lipid metabolisms. Further studies were needed to elucidate the mechanisms.


  • Detection of M 6 A-associated SNPs as Potential Functional Variants for Coronary Artery Disease

    by Xing-Bo Mo, Shu-Feng Lei, Yong-Hong Zhang, Huan Zhang

    Aim: To investigate the effects of m6A-single nucleotide polymorphisms (SNPs) on coronary artery disease (CAD). Methods: We examined the association of m6A-SNPs with CAD in about 185,000 cases and controls and further performed eQTL and differential expression analyses to support the identified m6A-SNPs. Results: Among the 4390 m6A-SNPs detected, 304 seemed to be associated with CAD (p < 0.05). SNP rs12286 was significantly associated with CAD at genome-wide level (p = 4.5 × 10−9). rs12286 was predicted to influence m6A methylation and have the potential to alter regulatory motifs binding, which may in turn regulate the expression of ADAMTS7 (p = 1.26 × 10−8). Conclusion: The present study found plenty of CAD-associated m6A-SNPs and demonstrated the potential functionality of the identified SNPs.